Table 3.
Generation of pluripotent cells from various sources and the different criteria used for assessing developmental potential.
Donor cell/ tissue |
Pluripotent cells |
Criteria for pluripotency | ref | ||||
---|---|---|---|---|---|---|---|
In vitro differentiation |
Teratoma | Postnatal chimera |
Germ line |
4n complementation | |||
Murine oocyte | Parthogenetic ES cells |
Yes | Yes | Yes | Yes | No | 1 |
Blastomere | ES | 2 | |||||
ICM | Yes | 3 | |||||
PGC | EG, EC | No | 4 | ||||
Spermato-gonial stem cells |
GMCS, maSSC, MASC |
5 | |||||
Epiblast | EpiSC | No | No | 6 | |||
Human oocyte | Parthogenetic ES cells |
7 | |||||
Human blastocyst |
Hu ES cells | 8 | |||||
Bone marrow derived cells |
MAPC | No | ? | 9 | |||
Cord blood cells |
No | 10 | |||||
Neural cells | Neurosphere derived |
11 |
All cells listed were able to differentiate in vitro, which represents the least stringent criterion for developmental potential. Only murine oocyte, blastocyst and spermatogonial stem cell derived cells were able to generate chimeras and contribute to the germ line. .
References: 1 (Narasimha et al., 1997); 2 (Wakayama et al., 2007); 3 (Eggan et al., 2001; Evans and Kaufman, 1981; Martin, 1981); 4 (Matsui et al., 1992; Resnick et al., 1992); 5 (Guan et al., 2006; Kanatsu-Shinohara et al., 2004; Seandel et al., 2007); 6 (Brons et al., 2007; Tesar et al., 2007); 7 (Cibelli et al., 2002; Revazova et al., 2007); 8 (Thomson et al., 1998); 9 (Jiang et al., 2002; Phinney and Prockop, 2007); 10 (van de Ven et al., 2007); 11 (Clarke et al., 2000).